The Globe and Mail reports in its Wednesday, June 17, edition that a cyber extortion group called FulcrumSec claimed to have stolen over a terabyte of data from Novo Nordisk. A Reuters dispatch to The Globe reports that they demanded $25-million (U.S.) but are now considering selling parts of the data. Their extensive theft included company source code, proprietary drug information, trial data, as well as employee, doctor and patient details collected over two months. Novo Nordisk did not immediately respond to a request for comment about FulcrumSec's claims. Reuters could not immediately verify the authenticity of the data posted by the hacking group. The company disclosed a cybersecurity incident on June 11 that it said involved unauthorized access to a limited number of internal IT systems that included access to certain personal data. FulcrumSec said that after Novo Nordisk refused to pay $25-million (U.S.), it was "exploring private sales" for some of the data related to certain drugs and other internal data. Lab 1's Thomas Willkan said the hacking group is "usually quite legit in terms of both their capabilities and also their claims." FulcrumSec said it would not release certain stolen data.